RVVC

2 stories · following the connections

Business

Cidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVC

By Nasdaq OMXFeb 21, 2017, 12:30 PM UTC

Business

Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results

By Nasdaq OMXNov 10, 2016, 9:11 PM UTC